Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Aslett
Observed names:
Aslett, Laura,
L Aslett
Observed institutions:
Imperial College London,
University of Edinburgh
OpenAlex ID:
A5082967190
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial
2024
·
Madeleine Eriksson
, Raza Hayat
, et al.
·
The Lancet Neurology
·
20
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI)
2024
·
Julia Wade
, Nicola Farrar
, et al.
·
EClinicalMedicine
·
7
PDF
The effects of kisspeptin on food intake in women with overweight or obesity
2023
·
Chioma Izzi‐Engbeaya
, Muhammad M. Choudhury
, et al.
·
Diabetes Obesity and Metabolism
·
7
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
FRI007 Kisspeptin Does Not Affect Food Intake In Women With Overweight Or Obesity
2023
·
Chioma Izzi-Engbeaya
, Muhammad Choudhury
, et al.
·
Journal of the Endocrine Society
PDF
Kisspeptin does not have detrimental metabolic effects in women
2023
·
Chioma Izzi-Engbeaya
, Muhammad Choudhury
, et al.
·
Endocrine Abstracts
Author response for "The effects of kisspeptin on food intake in women with overweight or obesity"
2023
·
Chioma Izzi‐Engbeaya
, Muhammad Choudhury
, et al.
Author response for "The effects of kisspeptin on food intake in women with overweight or obesity"
2023
·
Chioma Izzi‐Engbeaya
, Muhammad Choudhury
, et al.
Show more works
View as search
Works count:
14
Citation count:
579
H-index:
7
I10-index:
6
Year
Topic
Type
